Haymarket names Dattoli publisher of MM&M, PMD

Share this article:
Dattoli will oversee MM&M and the PMD
Dattoli will oversee MM&M and the PMD
Haymarket Media named Scott Dattoli publisher of MM&M and the Pharmaceutical Marketers Directory (PMD), a new position. He assumes full responsibility for editorial and business operations on the two titles, including digital products and events, and reports to Lisa Kirk, managing director, marketing and technology publications at Haymarket.
Dattoli joins Haymarket from Highline Media, where he was publisher of The National Underwriter Life & Health for the past two years. Prior to that, Dattoli spent seven years at SourceMedia (formerly Thomson Corp.), where he was associate publisher and then publisher of Securities Industry News.
“We're excited to add someone with Scott's depth and range of publishing experience to our management team,” said Kirk, “and we know MM&M and PMD will benefit from the singular focus of a dedicated brand champion.”
Haymarket acquired CPS Communications, the then-owner of MM&M and the PMD, in 2001.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...